Description
Teclistamab, sold under the brand name Tecvayli, is a human bispecific monoclonal antibody used for the treatment of relapsed and refractory multiple myeloma. It is a bispecific antibody that targets the CD3 receptor expressed on the surface of T-cells and B-cell maturation antigen (BCMA), which is expressed on the surface of malignant multiple myeloma B-lineage cells.
Teclistamab is the first bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. Teclistamab was approved for medical use in the European Union in August 2022, and in the United States in October 2022.The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
How and where to buy teclistamab?
teclistamab is a Generic Name for the trade name drug TECVAYLI. TECVAYLI® is approved by the FDA. Date of approval: 2022. TECVAYLI is supplied as Injection • 30 mg/3 mL (10 mg/mL) in a single-dose vial and • 153 mg/1.7 mL (90 mg/mL) in a single-dose vial (3). teclistamab can be ordered on request direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery at Delhi, Gurgaon, Noida, Ghaziabad, Chandigarh, Dehradun, Jaipur, Agra, Vadodara, Surat, Ahmedabad, Mumbai, Pune. Bhopal, Nagpur, Srinagar, Visakhapatnam, Vijayawada, Chennai, Bangalore, Thiruvananthapuram, Kerala, Guwahati, Kolkata, Mumbai. To get best retail price/cost of teclistamab in India, Call 8750295029 or Email [email protected]
We can help facilitate the supply of TECVAYLI through legal channels.